USDA will host a webinar today, focused on the potential economic effects of restricting antibiotic use as presented in the recently released ERS report, The Economics of Antibiotic Use in U.S. Livestock Production.
ERS Economist Stacy Sneeringer will lead the event, scheduled for 12 p.m. Central time. Registration details are available on the UDSA website.
In its recent report, USDA explains that U.S. farmers use antibiotics to treat, control, and prevent disease in their livestock, but also to increase productivity.
"Concern is growing that excessive antibiotic use in livestock and humans will contribute to the emergence of organisms that are resistant to most or all antibiotics. Due to this concern, pressure is mounting to limit the use of antibiotics in livestock production," USDA says.
In 2013, the U.S. Food and Drug Administration issued final guidance implementing voluntary plans to phase out the use of medically important antibiotics in livestock for production purposes.
In an August 2015 progress report, FDA said all of the affected drug sponsors had committed in writing to make changes described in the guidance. Some have implemented changes to their affected antimicrobial products – three applications have been converted from over-the-counter to prescription dispensing status; production indications have been withdrawn from one application; and 32 affected applications have been completely withdrawn, FDA said.
Additionally, FDA finalized the veterinary feed directive in June, which brings the feed-use of medically important antibiotics under the oversight of licensed veterinarians.
Sign up for the webinar on the USDA website.